Xcellerex fast-tracks second single-use bioprocessing facility

Xcellerex has started construction on a cGMP biomanufacturing facility based on its portable FlexFactory platform, which incorporates the company's single-use technology. The project, at the company's Massachusetts headquarters location, is projected to be complete in September. The facility will be the company's second at that location. Release (.pdf)

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.